Differing perspectives on antiviral treatment efficacy in patients co-infected with HIV and HCV

(European Association for the Study of the Liver) Two separate studies presented today at The International Liver Congress™ 2016 in Barcelona, Spain have offered alternative conclusions regarding the efficacy of direct-acting antivirals (DAAs) among patients co-infected with HIV and hepatitis C virus (HCV).